blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3865140

EP3865140 - PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CLOSTRIDIUM DIFFICILE INFECTION [Right-click to bookmark this link]
Former [2021/33]<SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? ?PREVENTIVE AND/OR THERAPEUTIC AGENT FORINFECTION
[2022/19]
StatusThe application has been withdrawn
Status updated on  02.08.2024
Database last updated on 22.08.2024
FormerRequest for examination was made
Status updated on  16.07.2021
FormerThe international publication has been made
Status updated on  18.04.2020
Most recent event   Tooltip02.08.2024Withdrawal of applicationpublished on 04.09.2024 [2024/36]
Applicant(s)For all designated states
Nutri Co., Ltd.
1-122 Fuji-cho
Yokkaichi-shi
Mie 510-0013 / JP
[2021/33]
Inventor(s)01 / KAWAGUCHI, Susumu
c/o Nutri Co., Ltd., 1-122, Fuji-cho
Yokkaichi-shi, Mie 510-0013 / JP
02 / KATO, Miho
c/o Nutri Co., Ltd., 1-122, Fuji-cho
Yokkaichi-shi, Mie 510-0013 / JP
 [2021/33]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2021/33]
Application number, filing date19870609.504.10.2019
[2021/33]
WO2019JP39254
Priority number, dateJP2018019148810.10.2018         Original published format: JP 2018191488
[2021/33]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020075637
Date:16.04.2020
Language:JA
[2020/16]
Type: A1 Application with search report 
No.:EP3865140
Date:18.08.2021
Language:EN
[2021/33]
Type: A8 Corrected patent application 
No.:EP3865140
Date:18.05.2022
[2022/20]
Search report(s)International search report - published on:JP16.04.2020
(Supplementary) European search report - dispatched on:EP07.10.2022
ClassificationIPC:A61K35/744, A61P31/04, A23L33/135
[2022/45]
CPC:
A61P31/04 (EP,KR,US); A61K35/744 (EP,KR,US); A23L33/135 (EP,KR);
A61K9/0053 (US); A23V2002/00 (KR); A23V2200/324 (KR)
Former IPC [2021/33]A61K35/744, A23L33/135, A61P31/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/33]
TitleGerman:PRÄVENTIVES UND/ODER THERAPEUTISCHES MITTEL FÜR CLOSTRIDIUM DIFFICILE-INFEKTION[2022/19]
English:PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CLOSTRIDIUM DIFFICILE INFECTION[2022/19]
French:AGENT PRÉVENTIF ET/OU THÉRAPEUTIQUE POUR UNE INFECTION PAR CLOSTRIDIUM DIFFICILE[2022/21]
Former [2021/33]<SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? PROPHYLAKTIKUM UND/ODER THERAPEUTIKUM FÜR INFEKTION
Former [2021/33]<SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? ?PREVENTIVE AND/OR THERAPEUTIC AGENT FORINFECTION
Former [2021/33]<SMALLCAPS/>? ? ?CLOSTRIDIUM? ? ? ? ?AGENT PROPHYLACTIQUE ET/OU THÉRAPEUTIQUE CONTRE LES INFECTIONS À <NS1:I> DIFFICILE</NS1:I>
Entry into regional phase10.05.2021Translation filed 
10.05.2021National basic fee paid 
10.05.2021Search fee paid 
10.05.2021Designation fee(s) paid 
10.05.2021Examination fee paid 
Examination procedure10.05.2021Examination requested  [2021/33]
20.04.2023Amendment by applicant (claims and/or description)
31.07.2024Application withdrawn by applicant  [2024/36]
Fees paidRenewal fee
04.10.2021Renewal fee patent year 03
13.10.2022Renewal fee patent year 04
16.10.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]US2016158295  (AFEYAN NOUBAR B [US], et al) [X] 1-3,6-9,12-15 * paragraphs [0084] - [0094] - [0097] - [0120] - [0191]; examples 1,8,10; claim 7 * [I] 1-15;
 [XI]  - MANSOUR NAHLA M ET AL, "Inhibition ofin Mice Using a Mixture of Potential Probiotic StrainsNM815,.NM915, andNM1015: Novel Candidates to ControlInfection (CDI)", PROBIOTICS AND ANTIMICROBIAL PROTEINS, NEW YORK, NY ; HEIDELBERG : SPRINGER, NEW YORK, NY ; HEIDELBERG : SPRINGER, vol. 10, no. 3, doi:10.1007/S12602-017-9285-7, ISSN 1867-1306, (20170511), pages 511 - 522, (20170511), XP037240333 [X] 1-3,6-8,11,12,15 * discussion * [I] 1-15

DOI:   http://dx.doi.org/10.1007/s12602-017-9285-7
International search[Y]JP2002179580  (GU ZENWA, et al) [Y] 4* , experimental example 1 (Family: none) *;
 [Y]JP2003261453  (NIPPON BERUMU KK) [Y] 4 * , claims, example 1 (Family: none) *;
 [XY]JP2007320946  (ADVANCE CO LTD) [X] 1-3, 5-23 * , claims, paragraph [0002] (Family: none) * [Y] 4;
 [Y]WO2018139503  (NUTRI CO LTD [JP]) [Y] 4 * , examples & AU 2018212041 A, examples & CA 3050675 A *;
 [X]  - Anonymous, "Relationship between Intestinal flora and lifestyle-related diseases and dietary habits [Industry Reportage "Intestinal Flora and Lifestyle-related Diseases" and Dietary Relationships--Latest Research Presented at Yakult Bioscience Research Foundation]", Food Industry, (20000000), vol. 44, no. 1 (975), ISSN 0559-8990, pages 26 - 29, XP009527685 [X] 1, 2, 5-23
 [X]  - T. Yamamoto-Osaki, S. Kamiya, S. Sawamura, M. Kai, A. Ozawa, "Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture", Journal of Medical Microbiology, (19940000), vol. 40, doi:10.1099/00222615-40-3-179, ISSN 0022-2615, pages 179 - 187, XP055700799 [X] 1, 2, 5-23 * , abstract, fig. 1, 2 *

DOI:   http://dx.doi.org/10.1099/00222615-40-3-179
by applicantJP2018191488
    - "Basic science and clinical aspect of Clostridium difficile infection", Modern Media, vol. 56, no. 10, (20100000), URL: www.eiken.co.ip/modernmedia/backnumber/pdf/MM1010_01.pdf
    - YAKUGAKU ZASSHI, (19920000), vol. 113, pages 396 - 399
    - Journal of Animal Clinical Research, (19940000), vol. 3, pages 11 - 20
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.